Theorem Clinical Research

Massachusetts General Hospital

Center for Connected Health, Daiichi Sankyo ink mobile app agreement

Thursday, October 23, 2014 01:19 PM

The Center for Connected Health, a division of Partners HealthCare, a Boston-based healthcare delivery system founded by Harvard Medical School affiliated teaching institutions Brigham and Women's Hospital and Massachusetts General Hospital, has announced a co-development agreement with Japanese pharmaceutical Daiichi Sankyo to create a mobile app to serve as a coaching platform for patients with atrial fibrillation who have been prescribed oral anticoagulation therapy.

More... »


PPD acquires RCT Logic's exclusive license to clinical trial design technology

Monday, September 8, 2014 01:50 PM

Pharmaceutical Product Development (PPD), a Wilmington, N.C.-based CRO, has acquired RCT Logic's exclusive license from Massachusetts General Hospital (MGH) for the portfolio of patents related to its sequential parallel comparison design (SPCD).

More... »


AWARE for All Clinical Research Education Day returns to Boston

Monday, August 4, 2014 02:53 PM

The Center for Information and Study on Clinical Research Participation (CISCRP), a nonprofit organization dedicated to engaging the public and patients as partners in the clinical research process, has announced the return of AWARE for All Boston, a free event designed to promote understanding and dialogue around clinical research participation.

More... »

NIH adds six clinical sites in Undiagnosed Diseases Network

Wednesday, July 2, 2014 12:40 PM

The NIH has awarded grants to six medical centers around the country to select from the most difficult-to-solve medical cases and together develop effective approaches to diagnose them. The new clinical sites added to the NIH Undiagnosed Diseases Network (UDN) will conduct clinical evaluation and scientific investigation in cases that involve patients with prolonged, undiagnosed conditions.

More... »

AZTherapies to start enrolling for phase III study of ALZT-OP1 in early Alzheimer's

Friday, May 23, 2014 11:27 AM

AZTherapies, a company developing novel treatments for Alzheimer's disease based on technology licensed from Massachusetts General Hospital, has received notice from FDA that it may proceed with the phase III clinical study submitted in its IND application. This study is for its lead program, ALZT-OP1, a novel combination therapy for the prevention and treatment of early Alzheimer's disease (AD).

More... »

Infinity appoints Baselga, Berkowitz to board of directors

Thursday, March 13, 2014 11:26 AM

Infinity Pharmaceuticals has appointed José Baselga M.D., Ph.D., and Jeff Berkowitz as independent members of its board of directors. Baselga, physician-in-chief at Memorial Sloan-Kettering Cancer Center, is an accomplished clinician and a thought leader in the PI3K field. Berkowitz, as the president of Walgreens Boots Alliance Development in Europe, has experience in pharmaceuticals, pharmacy, distribution and market access, pricing and reimbursement.

More... »

MGH, Broad Institute, Amgen collaborate on IBD therapies

Friday, January 17, 2014 11:44 AM

Massachusetts General Hospital (MGH), the Broad Institute and Amgen have launched a strategic collaboration to jointly discover and validate new therapeutic targets and develop novel therapies for inflammatory bowel disease (IBD), a chronic disorder that affects millions worldwide. The MGH-Broad-Amgen collaboration brings together scientists with experience in clinical medicine, IBD biology, human genetics, genomic technology and drug discovery to work together to help create a new world of therapeutic options for IBD patients.

More... »

Perrigo names board of directors

Friday, December 20, 2013 02:11 PM

Dublin, Ireland-based Perrigo has announced the appointment of its board of directors, effective until Perrigo’s annual general meeting scheduled for November 2014. The appointment of the Perrigo board follows the completion of Perrigo’s acquisition of Elan in a cash and stock transaction valued at approximately $8.6 billion. The transaction will create a global healthcare company with a growth profile.

More... »

Michael Seiden named CMO for McKesson Specialty Health, U.S. Oncology Network

Friday, September 6, 2013 03:09 PM

McKesson Specialty Health and The U.S. Oncology Networkhave appointed of Michael V. Seiden, M.D., Ph.D. as chief medical officer.

More... »

Sanofi, Mass. General Hospital launch oncology research collaboration

Thursday, October 11, 2012 07:00 AM

Global healthcare company Sanofi has formed a two-year agreement with Massachusetts General Hospital (MGH) aimed at furthering translational medicine research to develop new treatments for various types of hematological malignancies and solid tumors.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 20

Toronto Star, with FDA data, exposes weaknesses in Health Canada's clinical trial, inspection oversight

Crowdsourcing effort aims to fund updated online social media guide for sponsor interaction with patients

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs